Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2

American Academy of Pediatrics (AAP) - Tập 146 Số 2 - 2020
Hoi See Tsao1,2,3, Hannah M. Chason1, Deirdre M. Fearon1,2
1Department of Emergency Medicine and
2Department of Pediatrics, Warren Alpert Medical School, Brown University, Providence, Rhode Island
3School of Public Health

Tóm tắt

Immune thrombocytopenia (ITP) is a potential presentation of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing should be considered in these patients to allow for appropriate hospital triaging and isolation to limit community spread and health care worker infection during epidemics or pandemics. ITP is characterized by isolated thrombocytopenia. Approximately two-thirds of children with primary ITP have a history of a viral infection during the previous month.1,2 Viruses commonly identified as triggers include cytomegalovirus, hepatitis C, herpes, varicella zoster, Epstein-Barr, influenza, and HIV.3–7 In this case report, we describe the first documented case of a pediatric patient with ITP who tested positive for SARS-CoV-2. This case raises awareness of ITP as a possible pediatric presentation of coronavirus disease.

Từ khóa


Tài liệu tham khảo

Kühne, 2003, A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group, J Pediatr, 143, 605, 10.1067/S0022-3476(03)00535-3

Zeller, 2005, Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease, Acta Paediatr, 94, 178, 10.1080/08035250410025294

DiMaggio, 2009, Cytomegalovirus can make immune thrombocytopenic purpura refractory, Br J Haematol, 146, 104, 10.1111/j.1365-2141.2009.07714.x

Rand, 1998, Virus-associated idiopathic thrombocytopenic purpura, Transfus Sci, 19, 253, 10.1016/S0955-3886(98)00039-3

Espinoza, 1974, Viral infection of megakaryocytes in varicella with purpura, Am J Clin Pathol, 61, 203, 10.1093/ajcp/61.2.203

Kitamura, 1994, Idiopathic thrombocytopenic purpura after human herpesvirus 6 infection, Lancet, 344, 830, 10.1016/S0140-6736(94)92390-6

Hamada, 2004, A case of varicella-associated idiopathic thrombocytopenic purpura in adulthood, J Dermatol, 31, 477, 10.1111/j.1346-8138.2004.tb00536.x

Malleson, 2010, Review for the generalist: the antinuclear antibody test in children - when to use it and what to do with a positive titer, Pediatr Rheumatol Online J, 8, 27, 10.1186/1546-0096-8-27

McCrae, 2011, Immune thrombocytopenia: no longer ‘idiopathic’, Cleve Clin J Med, 78, 358, 10.3949/ccjm.78gr.10005

Kühne, 2011, Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group, Haematologica, 96, 1831, 10.3324/haematol.2011.050799

Berchtold, 1989, Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura, Blood, 74, 1600, 10.1182/blood.V74.5.1600.1600

Imbach, 2006, Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS), Pediatr Blood Cancer, 46, 351, 10.1002/pbc.20453

Rosthøj, 2003, Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort, J Pediatr, 143, 302, 10.1067/S0022-3476(03)00245-2

Donato, 2009, Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina, Pediatr Blood Cancer, 52, 491, 10.1002/pbc.21872

Rosthøj, 2012, Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort, Acta Paediatr, 101, 761, 10.1111/j.1651-2227.2012.02671.x

Provan, 2019, Updated international consensus report on the investigation and management of primary immune thrombocytopenia, Blood Adv, 3, 3780, 10.1182/bloodadvances.2019000812

Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with covid-19, N Engl J Med, 382, e43, 10.1056/NEJMc2010472

Wang, 2004, Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection, Clin Infect Dis, 39, 790, 10.1086/423384

Scaradavou, 2002, HIV-related thrombocytopenia, Blood Rev, 16, 73, 10.1054/blre.2001.0188

Shaikh, 2009, Thrombocytopenia in malaria, J Coll Physicians Surg Pak, 19, 708

Akel, 2017, Hematologic manifestations of babesiosis, Ann Clin Microbiol Antimicrob, 16, 6, 10.1186/s12941-017-0179-z

Pui, 1980, Evans syndrome in childhood, J Pediatr, 97, 754, 10.1016/S0022-3476(80)80258-7

Li, 2016, Updated understanding of autoimmune lymphoproliferative syndrome (ALPS), Clin Rev Allergy Immunol, 50, 55, 10.1007/s12016-015-8466-y

Cines, 2014, Pathogenesis of immune thrombocytopenia, Presse Med, 43, e49, 10.1016/j.lpm.2014.01.010

Campuzano-Maya, 2014, Hematologic manifestations of Helicobacter pylori infection, World J Gastroenterol, 20, 12818, 10.3748/wjg.v20.i36.12818

Ding, The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China [published online ahead of print March 20, 2020], J Med Virol

Wang M, Wu Q, Xu W, et al Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. February 18, 2020. medRxiv. doi:10.1101/2020.02.12.20022327

Shah N . Higher co-infection rates in COVID19. Medium. March 18, 2020. https://medium.com/@nigam/higher-co-infection-rates-in-covid19-b24965088333. Accessed 10 April, 2020

Dong, 2020, Epidemiology of COVID-19 among children in China, Pediatrics, 145, e20200702, 10.1542/peds.2020-0702

Lu, 2020, SARS-CoV-2 infection in children, N Engl J Med, 382, 1663, 10.1056/NEJMc2005073

Thông tin
Thông tin xuất bản

American Academy of Pediatrics (AAP)

Tập 146 Số 2

Thông tin tác giả